Silvia Ferrari

Prognostic value of anti-ADAMTS13 antibody features (Ig isotype, titer, and inhibitory effect) in a cohort of 35 adult French patients undergoing a first episode of thrombotic microangiopathy with undetectable ADAMTS13 activity

Silvia Ferrari, Friedrich Scheiflinger, Manfred Rieger et al. · Blood · 2006 · 292 citations · Full text

IgG subclass distribution of anti‐ADAMTS13 antibodies in patients with acquired thrombotic thrombocytopenic purpura

Silvia Ferrari, Geert C. Mudde, Michael Rieger et al. · Journal of Thrombosis and Haemostasis · 2009 · 191 citations · Full text

Thrombosis, Igg Subclass Distribution, Anti‐adamts13 Antibodies +9

Sleeping Beauty–engineered CAR T cells achieve antileukemic activity without severe toxicities

Chiara F. Magnani, Giuseppe Gaipa, Federico Lussana et al. · Journal of Clinical Investigation · 2020 · 183 citations · Full text

von Willebrand factor cleaving protease (ADAMTS‐13) and ADAMTS‐13 neutralizing autoantibodies in 100 patients with thrombotic thrombocytopenic purpura

Flora Peyvandi, Silvia Ferrari, Silvia Lavoretano et al. · British Journal of Haematology · 2004 · 154 citations

Immunology, Pathology, Thrombosis +19

A randomized, multicenter, phase II study of vandetanib monotherapy versus vandetanib in combination with gemcitabine versus gemcitabine plus placebo in subjects with advanced biliary tract cancer: the VanGogh study

Armando Santoro, Vittorio Gebbia, Tiziana Pressiani et al. · Annals of Oncology · 2014 · 116 citations · Full text

Medicine, Gemcitabine Versus Gemcitabine, Biliary Cancer +7